» Articles » PMID: 39861024

Introduction of Vector-Borne Infections in Europe: Emerging and Re-Emerging Viral Pathogens with Potential Impact on One Health

Overview
Journal Pathogens
Date 2025 Jan 25
PMID 39861024
Authors
Affiliations
Soon will be listed here.
Abstract

The rise and resurgence of vector-borne diseases (VBDs) in Europe pose an expanding public health challenge, exacerbated by climate change, globalization, and ecological disruptions. Both arthropod-borne viruses (arboviruses) transmitted by ticks such as Crimean-Congo hemorrhagic fever and arboviruses transmitted by mosquitoes like dengue, Chikungunya, Zika, and Japanese encephalitis have broadened their distribution due to rising temperatures, changes in rainfall, and increased human mobility. By emphasizing the importance of interconnected human, animal, and environmental health, integrated One Health strategies are crucial in addressing this complex issue. Europe faces increased risk due to the expanding habitats of disease-carrying organisms, the spread of new species like since 2013, and increased movement of infected individuals between countries, leading European countries to implement strategies such as enhanced surveillance systems, public awareness campaigns, and prompt outbreak response strategies. However, the lack of both targeted antiviral therapies and vaccines for many arboviruses, together with undetected or asymptomatic cases, hamper containment efforts. Therefore, it is important to have integrated strategies that combine climate modeling, disease surveillance, and public health interventions to address expected changes in disease patterns due to global changes. This review explores the spread of arboviruses in Europe, highlighting their historical context, current transmission dynamics, and their impact on public health.

References
1.
de Lima Cavalcanti T, Pereira M, de Paula S, Franca R . A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development. Viruses. 2022; 14(5). PMC: 9147731. DOI: 10.3390/v14050969. View

2.
Rossi B, Barreca F, Benvenuto D, Braccialarghe N, Campogiani L, Lodi A . Human Arboviral Infections in Italy: Past, Current, and Future Challenges. Viruses. 2023; 15(2). PMC: 9963149. DOI: 10.3390/v15020368. View

3.
Tappe D, Kapaun A, Emmerich P, de Mendonca Campos R, Cadar D, Gunther S . O'nyong-nyong virus infection imported to Europe from Kenya by a traveler. Emerg Infect Dis. 2014; 20(10):1766-7. PMC: 4193281. DOI: 10.3201/eid2010.140823. View

4.
Fox J, Huang L, Tahan S, Powell L, Crowe Jr J, Wang D . A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice. PLoS Pathog. 2020; 16(8):e1008743. PMC: 7433899. DOI: 10.1371/journal.ppat.1008743. View

5.
Vanlandingham D, Hong C, Klingler K, Tsetsarkin K, McElroy K, Powers A . Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes. Am J Trop Med Hyg. 2005; 72(5):616-21. View